AU2002362710A1 - Use of thymulin-like peptides for making pain-relieving medicines - Google Patents
Use of thymulin-like peptides for making pain-relieving medicinesInfo
- Publication number
- AU2002362710A1 AU2002362710A1 AU2002362710A AU2002362710A AU2002362710A1 AU 2002362710 A1 AU2002362710 A1 AU 2002362710A1 AU 2002362710 A AU2002362710 A AU 2002362710A AU 2002362710 A AU2002362710 A AU 2002362710A AU 2002362710 A1 AU2002362710 A1 AU 2002362710A1
- Authority
- AU
- Australia
- Prior art keywords
- thymulin
- peptides
- relieving medicines
- pain
- making pain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drugs Drugs 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0112984A FR2830451B1 (en) | 2001-10-09 | 2001-10-09 | USE OF THYMULIN-LIKE PEPTIDES (PAT) FOR THE MANUFACTURE OF PAIN MEDICATIONS |
| FR0112984 | 2001-10-09 | ||
| PCT/FR2002/003428 WO2003030927A2 (en) | 2001-10-09 | 2002-10-08 | Use of thymulin-like peptides for making pain-relieving medicines |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| AU2002362710B8 AU2002362710B8 (en) | 2003-04-22 |
| AU2002362710A1 true AU2002362710A1 (en) | 2003-07-03 |
| AU2002362710B2 AU2002362710B2 (en) | 2007-06-28 |
Family
ID=8868083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002362710A Ceased AU2002362710B2 (en) | 2001-10-09 | 2002-10-08 | Use of thymulin-like peptides for making pain-relieving medicines |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7309690B2 (en) |
| EP (1) | EP1450843B1 (en) |
| JP (1) | JP4277684B2 (en) |
| AT (1) | ATE334694T1 (en) |
| AU (1) | AU2002362710B2 (en) |
| CA (1) | CA2463549C (en) |
| DE (1) | DE60213648T2 (en) |
| ES (1) | ES2272811T3 (en) |
| FR (1) | FR2830451B1 (en) |
| IL (2) | IL161319A0 (en) |
| WO (1) | WO2003030927A2 (en) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| MXPA05008097A (en) | 2003-01-28 | 2006-02-08 | Microbia Inc | Methods and compositions for the treatment of gastrointestinal disorders. |
| CN102772783A (en) * | 2007-01-25 | 2012-11-14 | 中国生化制药工业协会 | Application of serum thymus factor in preparation of protecting drugs of antineoplastic drugs, and tumour physical and chemical treatment drugs |
| US20100120694A1 (en) | 2008-06-04 | 2010-05-13 | Synergy Pharmaceuticals, Inc. | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| US7879802B2 (en) | 2007-06-04 | 2011-02-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| FR2930156B1 (en) * | 2008-04-21 | 2011-10-28 | Cll Pharma | USE OF NONAPEPTIDE PAT IN THE TREATMENT OF AUTOIMMUNE DISEASES. |
| EP2321341B1 (en) | 2008-07-16 | 2017-02-22 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| CA2745694C (en) | 2008-12-03 | 2018-03-27 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase c agonists and methods of use |
| AU2009334511C1 (en) | 2008-12-31 | 2016-08-18 | Ardelyx, Inc. | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| WO2018129556A1 (en) | 2017-01-09 | 2018-07-12 | Ardelyx, Inc. | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| US9468662B2 (en) | 2010-07-12 | 2016-10-18 | Orphit | Use of the PAT nonapeptide in the treatment and prevention of neurodegenerative diseases |
| FR2962335B1 (en) * | 2010-07-12 | 2013-01-18 | Cll Pharma | USE OF PAT NONAPEPTIDE IN THE TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| MX357121B (en) | 2011-03-01 | 2018-06-27 | Synergy Pharmaceuticals Inc Star | Process of preparing guanylate cyclase c agonists. |
| US10376481B2 (en) | 2012-08-21 | 2019-08-13 | Ardelyx, Inc. | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| BR112015003527A2 (en) | 2012-08-21 | 2017-07-04 | Ardelyx Inc | compounds and methods for nhe-mediated antiport inhibition in the treatment of disorders associated with fluid retention or salt overload and disorders of the gastrointestinal tract. |
| CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| SI2983667T1 (en) | 2013-04-12 | 2019-09-30 | Ardelyx, Inc. | Nhe3-binding compounds and methods for inhibiting phosphate transport |
| BR112015030326A2 (en) | 2013-06-05 | 2017-08-29 | Synergy Pharmaceuticals Inc | ULTRAPURE GUANYLATE CYCLASE C AGONISTS, METHOD OF MANUFACTURING AND USING THEM |
| EP3463420A4 (en) * | 2016-06-06 | 2020-02-12 | Clinical Stem Cells Pty Ltd | Peptides for hair growth |
| MX2019008171A (en) | 2017-01-09 | 2020-02-05 | Ardelyx Inc | Inhibitors of nhe-mediated antiport. |
| MX2019008170A (en) | 2017-01-09 | 2020-02-07 | Ardelyx Inc | Compounds useful for treating gastrointestinal tract disorders. |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1126261A (en) * | 1977-05-25 | 1982-06-22 | Jean-Francois Bach | Polypeptides and processes for the synthesis thereof |
| DK221681A (en) * | 1980-05-22 | 1981-11-23 | Inst Nat Sante | PROCEDURE FOR MANUFACTURING BIOLOGICAL ACTIVITIES AND RADIO-IMMUNOLOGICALLY APPLICABLE PRODUCTS FROM THE SERUM THYMUS FACTOR |
| JPS5852225A (en) * | 1981-09-22 | 1983-03-28 | Mitsui Pharmaceut Inc | Remedy for immune insufficiency |
| US5288706A (en) * | 1987-12-25 | 1994-02-22 | Mitsui Toatsu Chemicals, Incorporated | Medicament for prevention and remedy of diseases of the pancreas and others |
| JPH06192120A (en) * | 1992-12-24 | 1994-07-12 | Mitsui Toatsu Chem Inc | Preventing and therapeutic agent for damage and destruction of renal tissue and cell |
| JP3751986B2 (en) * | 1994-06-21 | 2006-03-08 | 英良 横沢 | Pharmaceutical composition |
| US5639726A (en) * | 1994-09-30 | 1997-06-17 | The Regents Of The University Of Michigan | Peptide mediated enhancement of thrombolysis methods and compositions |
| US5808009A (en) * | 1996-09-23 | 1998-09-15 | North Dakota State University Research Foundation | Method of affinity purifying antibodies |
-
2001
- 2001-10-09 FR FR0112984A patent/FR2830451B1/en not_active Expired - Fee Related
-
2002
- 2002-10-08 JP JP2003533958A patent/JP4277684B2/en not_active Expired - Fee Related
- 2002-10-08 CA CA2463549A patent/CA2463549C/en not_active Expired - Fee Related
- 2002-10-08 US US10/492,170 patent/US7309690B2/en not_active Expired - Lifetime
- 2002-10-08 IL IL16131902A patent/IL161319A0/en active IP Right Grant
- 2002-10-08 EP EP02800641A patent/EP1450843B1/en not_active Expired - Lifetime
- 2002-10-08 ES ES02800641T patent/ES2272811T3/en not_active Expired - Lifetime
- 2002-10-08 AT AT02800641T patent/ATE334694T1/en not_active IP Right Cessation
- 2002-10-08 WO PCT/FR2002/003428 patent/WO2003030927A2/en active IP Right Grant
- 2002-10-08 DE DE60213648T patent/DE60213648T2/en not_active Expired - Lifetime
- 2002-10-08 AU AU2002362710A patent/AU2002362710B2/en not_active Ceased
-
2004
- 2004-04-07 IL IL161319A patent/IL161319A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002362710A1 (en) | Use of thymulin-like peptides for making pain-relieving medicines | |
| AU2002302147A1 (en) | Pharmaceutical composition | |
| AU2002253039A1 (en) | Tramadol-based medicament | |
| AU2003289742A1 (en) | Stable therapeutic proteins | |
| AU2002258221A1 (en) | Medicinal composition | |
| AU2003276572A1 (en) | Pharmaceutical dosage forms of biguanide-sulfonylurea combinations | |
| AU2002353739A1 (en) | Therapeutic compounds | |
| AUPR535101A0 (en) | Novel therapeutic molecules | |
| AU2002244865A1 (en) | Pharmaceutical composition of ibuprofen | |
| AU2002333276A1 (en) | Drugs for vasculopaties | |
| AU2002238673A1 (en) | Human adrenomedullin-specific antibody, pharmaceutical composition containing same, therapeutic uses thereof | |
| AU2002255897A1 (en) | Ensemble-based strategy for the design of protein pharmaceuticals | |
| GB0129872D0 (en) | Novel pharmaceutical | |
| AU2002354460A1 (en) | Medicinal composition | |
| AU2001264900A1 (en) | Pharmaceutical use of fibulin-1 | |
| AUPR529701A0 (en) | Pharmaceutical composition | |
| AU2002365148A1 (en) | Human ras interacting protein | |
| AU2002342940A1 (en) | New pharmaceutical compounds | |
| AU2002361450A1 (en) | Novel pharmaceutical | |
| GB0130509D0 (en) | Novel pharmaceutical | |
| GB0129876D0 (en) | Novel pharmaceutical | |
| GB0130511D0 (en) | Novel pharmaceutical | |
| AU2002257630A1 (en) | Human mrp5-like protein | |
| GB0129871D0 (en) | Novel pharmaceutical | |
| AU2002100921A4 (en) | Pharmaceutical composition |